Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT06332131
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Sponsor: Abramson Cancer Center at Penn Medicine
View on ClinicalTrials.gov
Summary
This is an observational study that includes patients with breast cancer or non-small cell lung cancer who will be treated with immune checkpoint inhibitor (ICI) therapy. The investigators will use echocardiograms, blood draws, and PET stress tests to understand how ICI therapy affects the heart and circulatory system.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
25
Start Date
2025-01-15
Completion Date
2026-07
Last Updated
2026-02-09
Healthy Volunteers
No
Locations (1)
Abramson Cancer Center at University of Pennsylvania
Philadelphia, Pennsylvania, United States